Conformia Continues Focus on Pharma
Conformia, the California based Product Lifecycle Management provider, has enhanced its focus on the pharmaceutical industry with the releases of its Design Suite – a web based solution automating the design of new drugs during the lab scale environment. The solution completes Conformia’s pharma offering by creating a full end-to-end PLM solution ‘from lab to launch’.
Recent years have seen considerable growth in the development of PLM for the pharma industry, with a particular emphasis on enabling regulatory compliance. Datamonitor put PLM spend by pharma companies at almost US$500 million in 2007.
In July, Conformia announced the expansion of the Chemistry Manufacturing and Controls (CMC) Biotech Working Group, designed in conjunction with seven leading biotech companies to formulate case studies with a view to assuring quality in the manufacture of medicinal products. The group includes Amgen, Genentech, Abbott, Medlmmune, GlaxoSmithKine, Eli Lilly, and Pfizer.
